Pattern of rectal cancer recurrence following potentially curative surgical treatment

Survival in rectal cancer has been related mainly to clinical and pathological staging. Recurrence is the most challenging issue when surgical treatment of rectal cancer is concerned. This study aims to establish a recurrence pattern for rectal adenocarcinoma submitted to surgical treatment between June 2003 and July 2021. After applying the exclusion criteria to 305 patients, 166 patients were analyzed. Global recurrence was found in 18.7% of them, while 7.8% have had local recurrence. Recurrences were diagnosed from 5 to 92 months after the surgical procedure, with a median of 32.5 months. Follow-up varied from 6 to 115 months. Recurrence, in literature, is usually between 3 and 35% in 5 years and shows a 5-year survival rate of only 5%. In around 50% of cases, recurrence is local, confined to the pelvis. This study was consonant with the literature in most aspects evaluated, although a high rate of local recurrence remains a challenge in seeking better surgical outcomes. (AU)

Una mirada al cáncer colorrectal en Chile: aproximación individualizada de las cifras para el periodo 2016-2021 / A look at colorectal cancer in Chile: Individual approximation of the figures for the period 2016-2021

Introducción: El cáncer colorrectal (CCR) es la tercera enfermedad maligna más frecuente en el mundo y suele estudiarse como un solo concepto, a pesar de las diferencias entre las neoplasias que lo conforman. Dada la falta de trabajos actualizados, se ha realizado esta revisión epidemiológica para aproximarse a su verdadera magnitud en la población chilena. Materiales y Métodos: Este estudio es de carácter observacional, descriptivo, longitudinal y retrospectivo. Analizó las tasas de mortalidad a nivel nacional y regional entre 2016-2021 por cáncer de colon, unión rectosigmoidea y recto, utilizando datos de acceso público. Los criterios de inclusión consideraron todas las defunciones por las neoplasias mencionadas registradas en el DEIS, mientras que los criterios de exclusión corresponden a aquellas que por las mismas causas no fueron registradas o sucedieron fuera del período de estudio. No se requirió consentimiento informado ni revisión por parte de un comité de ética. Resultados: Se evidencia un aumento de las defunciones por cáncer de colon, principalmente en la zona centro-sur del país, sin una predilección significativa de género. Aunque la mortalidad por otras neoplasias estudiadas ha aumentado, no ha sido en igual cuantía. Discusión: La mortalidad por cáncer de colon es superior a la de otras neoplasias estudiadas, destacando la zona centro-sur del país, sin una tendencia específica por sexo en los fallecimientos. Esto podría explicarse por fallas en los mecanismos diagnósticos o diferencias en los hábitos alimenticios. Se necesitarían estudios adicionales para confirmar estas observaciones.

Introduction: Colorectal cancer (CRC) is the third most frequent malignant disease in the world, and although it is usually studied as a single entity (rectum-colon), the differences between both neoplasms are quantitatively significant. Therefore, in view of the lack of updated studies, this epidemiological review has been carried out to approximate its real magnitude in the Chilean population. Materials and Methods: Observational, descriptive, longitudinal, and retrospective study, where mortality rates were analyzed at the national and regional level, between 2016-2021, due to colon cancer. For this, publicly accessible data was used. Therefore, informed consent or review by an ethics committee was not required. Results: During the period studied, there is evidence of a clear rising trend in mortality rates, contributed mainly by the central-southern area of the country, without significant gender predilection. The mortality rate contributed by rectum and union neoplasm isn't significant enough like the colon ones. Discussion: Through this review, the systematic growth that this pathology has experienced in national mortality and its predilection for specific geographical areas are evident. The explanation for this could range from failures in diagnostic care mechanisms to marked differences in diet habits; more studies would be needed to confirm it.

Caracterización de enfermos operados de cáncer rectal. Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández / Characterization of patients operated of rectal cancer. Teaching Clinic-Surgical Hospital Faustino Pérez Hernández

RESUMEN Introducción: el cáncer de recto se considera una de las neoplasias más frecuentes del siglo XXI, con elevada mortalidad. Objetivo: caracterizar a los pacientes operados de cáncer rectal en el Hospital Universitario Clínico Quirúrgico Comandante Faustino Pérez Hernández, de Matanzas, entre enero de 2015 y diciembre de 2018. Materiales y métodos: se realizó un estudio observacional descriptivo. El universo fue de 97 pacientes de ambos sexos, operados de cáncer rectal. Se obtuvieron los datos de las historias clínicas individuales. Se analizaron variables como edad, sexo, localización específica del tumor, manifestaciones clínicas, características anatomopatológicas y estadios de la enfermedad, técnica quirúrgica empleada y complicaciones postoperatorias durante los primeros siete días. El método estadístico utilizado fue la distribución de frecuencia, en valores absolutos y porcentajes. Resultados: entre los pacientes operados de cáncer rectal, predominaron las personas de 70 a 79 años y el sexo masculino. El recto superior fue el sitio de mayor localización. El sangrado rectal, la expulsión de flemas y los cambios del hábito intestinal fueron los síntomas más frecuentes. El adenocarcinoma bien diferenciado fue la variedad histológica de mayor incidencia, y los estadios que prevalecieron fueron el II y el III. La técnica quirúrgica más empleada fue la resección anterior, y la complicación más frecuente la infección del sitio quirúrgico. Conclusiones: prevenir los factores de riesgo, sus causas predisponentes y desencadenantes, utilizar los medios diagnósticos convencionales y de avanzada. Detectar y tratar de forma temprana la enfermedad puede lograr mejor calidad de vida en estos pacientes (AU).

ABSTRACT Introduction: rectal cancer is considered one of the most frequent neoplasia of the 21st century, with high mortality. Objective: to characterize patients who underwent rectal cancer surgery at the Teaching Clinic-Surgical Hospital Faustino Pérez Hernández, of Matanzas, between January 2015 and December 2018. Materials and methods: a descriptive observational study was carried out. The universe was 97 patients of both sexes, who underwent a rectal cancer surgery. Data were obtained from individual medical records. Variables such as age, sex, specific tumor location, clinical manifestations, anatomopathologic characteristics and stages of the disease, surgical technique used and post-surgery complications during the first seven days were analyzed. The statistical method used was the frequency distribution, in absolute values and percentages. Results: people aged 70-79 years and men predominated among patients with rectal cancer. The upper rectum was the site of most common location. Rectal bleeding, phlegm expulsion, and changes in bowel habit were the most frequent symptoms. Well-differentiated adenocarcinoma was the most prevalent histological variety, and the stages that prevailed were II and III. The most commonly used surgical technique was anterior resection, and the most common complication was surgical site infection. Conclusions: to prevent risk factors, their predisposing causes and triggers; to use conventional and advanced diagnostic means. Early detection and treatment of the disease can achieve better quality of life in these patients (AU).

Disfunción ileostómica en pacientes sometidos a resección anterior baja por un cáncer del recto luego de neoadyuvancia / Ileostomic dysfunction in patients undergoing low anterior resection for rectal cancer after neoadjuvant treatment

Resumen Introducción: La resección anterior baja protegida con una ileostomía en asa (IA) luego de neoadyuvancia es el tratamiento estándar del cáncer del recto bajo localmente avanzado. Objetivos: Investigar la incidencia, características clínicas de la disfunción ileostómica (DI) en estos pacientes y, eventualmente, definir un perfil de riesgo. Materiales y Método: Se analizan 103 pacientes consecutivos. La DI se define como la eliminación por la ileostomía de más de 1,5 litros por día durante 3 o más días consecutivos asociado a distensión y dolor abdominal con intolerancia a la alimentación oral en ausencia de una complicación intraabdominal Clavien-Dindo grado III o mayor. Se comparan el grupo con DI del resto (no DI). Resultados: La DI se presentó en el 14,5% de los casos, se resolvió entre 12 y 70 días (en el 50% superó los 30 días), la tasa de reingreso fue 27% y no hubo reoperaciones en este grupo. No hubo diferencias estadísticamente significativas entre ambos grupos salvo en el tiempo de hospitalizarán y la tasa de reingresos. Discusión: La DI corresponde a un tipo de íleo posoperatorio de gravedad y duración variable que paradojalmente se asocia con la eliminación de altos volúmenes de contenido intestinal por la IA, requiere aporte vigoroso de volumen y electrolitos y en los casos más graves apoyo con nutrición parenteral. El cuadro revierte en plazos variables con manejo conservador. En este estudio no se ha logrado definir un perfil del paciente en riesgo de sufrir esta complicación o factores predictivos de ella.

Background: Diverting loop ileostomy (LI) is commonly performed to protect a distal anastomosis after a low anterior resection. Aim: To investigate the frecuency and clinical features of ileostomic dysfunction (ID) and, eventually, to define a profile of patients at risk of this complicaction. Materials and Method: 103 consecutive patients operated on for rectal cancer were included. ID is defined when the maxime output was more than 1,5 lt/day for three or more consecutive days with biochemical disturbances, associated to abdominal distension and the inability to tolerate oral feeding without postoperative severe complication. Patients with ID were compared with noID group. Results: ID developed in 15 patients, lasting between 12 and 70 days (50% for more then 30 days), the readmission rate was 27% without reoperation in this group. Except for inhospital time and readmission rate, no other difference between both groups were founded. Discussion: ID is a kind of paralitic ileus of variable intensity with paradox high output ileostomy leading to depletion of water and electrolyte imbalance. ID requires reposition of high volumen of fluids and electrolytes and sometimes parenteral nutrition with full recovery in variable periods without invasive treatment. In this study it was not possible to define a patient profile at risk or predictive factores of this complication.

Epidemiological and prognostic single center study of anal carcinoma / Estudo epidemiológico e prognóstico em um único centro de carcinoma anal

Abstract Background: Anorectal carcinoma includes the anal margin, the anal canal, and the lower rectum. The incidences of anal tumors represent 1.4 % of all gastrointestinal tumors. Patients and methods: Our study is retrospective and was conducted at Baghdad Medical City. Patient's data were collected from the medical records through a predesigned sheet that included the following information: demographic data, medical history, past-history, presenting symptoms, pathological data, and treatment details. Results: The median age was 49 years. As regard tumor extension, 85.71 % of patients had anal disease, while anorectal cancer was encountered in 14.28 % of cases only. Male to female ratio was 1:3. Most of cases were SCC 78.57 %. Only 11 patients (39.28 %) were diagnosed as Stage I, whereas 12 patients (42.85 %) had Stage II-III disease. Moderate differentiated tumors are the most common. The tumor mass located between 5-10 cm das a distance from anal verge in 12 (42.85 %) of patients. We found 6 (21.42 %) patients with positive virology tests with no specificity detected. APR was the mainstay for treatment of stage I disease. Neoadjuvant treatment followed by TME resection was the treatment found in locally advanced tumors. The mean Overall Survival (OS) for patients received neoadjuvant CRT in the study was 43.5 months, while, the mean OS was 45.73 months in the adjuvant setting. Univariate analysis for OS according to prognostic factors revealed that sites of cancer, grades and histopathology were significant independent prognostic factors for OS in this study. The anal canal tumor was associated with shorter OS (33.25) months in comparison to the anorectal cancer (OS = 47.22 months). Based on tumor grade, well and moderate differentiation have better OS (60.21 months) while, poorly grade was associated with shorter OS (43.07 months). On the concern of SCC, it was associated with shorter OS (37 months) in comparison to higher survival in patients with adenocarcinoma (46.13 months). Conclusion: Anal canal cancer has poorer prognosis than anorectal. The early-stage has a better OS that needs more effort for early diagnosis and treatment.

Resumo Antecedentes: O carcinoma anorretal inclui a margem anal, o canal anal e o reto inferior. A incidência de tumores anais representa 1.4 % de todos os tumores gastrointestinais. Pacientes e métodos: Nosso estudo é retrospectivo e foi realizado no Baghdad Medical City. Os dados do paciente foram coletados dos registros médicos por meio de uma folha pré-projetada que incluía as seguintes informações: dados demográficos, histórico médico, histórico anterior, sintomas de apresentação, dados patológicos e detalhes do tratamento. Resultados: A idade média foi de 49 anos. Quanto à extensão do tumor; 85,71 % dos pacientes apresentavam doença anal, enquanto o câncer anorretal foi encontrado em 14,28 % dos casos. A proporção homem/mulher foi de 1:3. A maioria dos casos foi de CEC 78,57 %. Apenas 11 pacientes (39,28 %) foram diagnosticados como Estágio I, enquanto 12 pacientes (42,85 %) apresentavam doença em Estágio II?III. Tumores diferenciados moderados são os mais comuns. A massa tumoral localizada entre 5-10 cm das distâncias da margem anal em 12 (42,85 %) dos pacientes. Foram encontrados 6 (21,42 % pacientes com testes virológicos positivos sem especificidade detectada. A TAEG foi a base para o tratamento da doença em Estágio I. O tratamento neoadjuvante seguido pela ressecção do TME foi o tratamento encontrado em tumores localmente avançados. A sobrevida global média OS dos pacientes que receberam TRC neoadjuvante no estudo foi de 43,5 meses, enquanto a OS média foi de 45,73 meses no cenário adjuvante. A análise univariada para OS de acordo com fatores prognósticos revelou que locais de câncer, notas e histopatologia foram fatores prognósticos independentes significativos para OS neste estudo. O tumor do canal anal foi associado a SG mais curtos 33,25 meses em comparação ao câncer anorretal OS = 47,22 meses. Com base no grau do tumor, a diferenciação boa e moderada apresenta melhor OS 60,21 meses, enquanto o grau ruim foi associado a um OS mais curto 43,07 meses. No que diz respeito ao CEC, este foi associado a uma OS mais curta 37 meses em comparação à maior sobrevida em pacientes com adenocarcinoma 46,13 meses. Conclusão: O câncer de canal anal tem pior prognóstico que o anorretal. O estágio inicial tem um sistema operacional melhor que precisa de mais esforço para diagnóstico e tratamento precoces.

Anatomía segmentaria del recto. Nuevo enfoque / Anatomy segmentation of the rectal. New approach

RESUMEN Se actualizó la clasificación anatómica del tumor de recto, con la revisión de varios tratados sobre anatomía. El estudio de la morfología interna del recto reconoce la formación de anchos pliegues. La formación de anchos pliegues de mucosas transversales, denominadas válvulas: una válvula inferior a 7 cm del ano, otra a 2 cm. Más arriba con una forma de media luna y la tercera a 11 cm del ano. Como estas válvulas son pliegues mucosos sin localización precisa no pueden ser consideradas como puntos anatómicos para segmentación del recto. De esta manera, la segmentación rectal como el límite entre recto superior e inferior se sitúa en la reflexión peritoneal; en el diagnóstico de tumores rectales la definición de su situación anatómica es importante para la conducta terapéutica, ya que el recto inferior tiene su origen embriológico en el proctodeo (ectoblástica) y puede ser más sensible a las radiaciones y los tumores del recto superior son tumores que se originan de tejido de formación entoblástica, las radiaciones producen lesiones del peritoneo y de otros órganos de la cavidad pelviana. La segmentación rectal es importante para el estadio locorregional del tumor y para la definición de un esquema de tratamiento adecuado. En primer lugar, establece el concepto anatómico de localización de un tumor de recto inferior, se diagnóstica con un tacto rectal, si es tocable es del recto inferior. En segundo lugar, define cuáles son los estudios complementarios para saber el estadio de la enfermedad y establece los parámetros anatómicos necesarios para la indicación del tratamiento neoadyuvante (AU).

SUMMARY To present a recent an anatomic classification of rectal tumor localization. Review of many anatomy treaties. The rectal internal morphology studies recognize the formation of thick folds of transversal mucosa thick folds named valves: a low valve to 7 cm from anus. Another is to 2 cm upper with a half moon form, a third one to 11 cm from anus. As this valves are mucosal folds without a clear localization they can't be consider as anatomical points to the rectum segment. Therefore, the rectal segmentation as the limit between up and low rectum, is located in the peritoneal reflection. In the rectal tumors diagnosis definition of it's anatomic situation is important for the therapeutic behavior, because the low rectum has its embryologic origin in the Proctodeum (ectoblastic). It can be more sensitive to the radiation the up rectum tumors are originated from the formation entoblast tissue (endoblast) the radiations cause peritoneal injuries and other pelvic cavity organs. The rectal segmentation is important for the locate-regional tumor stadium and for the appropriate treatment definition. In first place, establish the anatomic concept of the low rectal tumor localization. In second place defines which are the complementary for the new adjuvant indication (AU).

Clinico-epidemiologic criteria and predictors of survival of rectal cancer among Egyptians in Delta region / Critérios clínico-epidemiológicos e preditores de sobrevida do câncer retalentre egípcios na região do Delta

Abstract Background Colorectal cancer represents a global health problem. Rectal cancer in particular is increasing and is believed to carry a unique epidemiologic and prognostic criteria. Method We herein study retrospectively the data of 245 patients from a tertiary center in Egypt. Clinico-epidemiologic criteria and predictors of survival are analyzed. Results The disease affects younger population without sex predilection. Prognosis is affected by age, nodal status, metastasis, and bowel obstruction. Conclusion Rectal cancer has unique criteria in the Egyptian population. A national population based registry is recommended to delineate the nature of the disease in Egypt.

Resumo Introdução O câncer colorretal é um problema de saúde global. A incidência de câncer retal, em particular, está aumentando; acredita-se que esta neoplasia apresente critérios epidemiológicos e prognósticos únicos. Métodos O presente estudo avaliou retrospectivamente os dados de 245 pacientes de um centro terciário no Egito. Critérios clínico-epidemiológicos e preditores de sobrevida foram analisados. Resultados A doença afeta a população mais jovem, sem predileção por sexo. O prognóstico é afetado pela idade, estado nodal, metástase e obstrução intestinal. Conclusão O câncer retal apresenta critérios únicos na população egípcia. Recomenda-se um registro nacional de base populacional para delinear a natureza da doença no Egito.

Resección anterior del recto ultrabaja laparoscópica con anastomosis coloanal en cáncer del recto bajo / Laparoscopic Ultralow Anterior Rectal Resection with Coloanal Anastomosis in Low Rectum Cancer

RESUMEN Introducción: La resección anterior del recto ultrabaja laparoscópica con anastomosis coloanal evita la realización una colostomía definitiva. Objetivo: Determinar las indicaciones, describir la técnica quirúrgica y mostrar los resultados a largo plazo obtenidos en la realización de este proceder en el tratamiento del cáncer del recto bajo. Método: Se realizó un estudio observacional descriptivo y prospectivo de 53 pacientes con cáncer del recto bajo en el período comprendido entre octubre 2007 y noviembre 2018 en el Centro Nacional de Cirugía de Mínimo Acceso. Todas las resecciones fueron llevadas a cabo por un grupo dedicado a la cirugía colorrectal, en todos los casos se realizó la excisión total del mesorrecto. Resultados: Se operaron mediante esta técnica 53 pacientes, 30 masculinos y 23 femeninos con un promedio de edad de 57 años (rango 23-81) y de ellos 42 (79,2 por ciento) después de terapia neoadyuvante. El promedio de tiempo quirúrgico fue de 195 min (rango 90-360) y las pérdidas hemáticas estimadas, de 72 mL. La incidencia de morbilidad mayor fue de 16,9 por ciento (9/53) y la media de estadía hospitalaria de 6,3 días. La media del periodo de seguimiento fue de 40 meses (rango 1-132) con una recidiva local de 9,4 por ciento (5/53) y una supervivencia global a los 5 años de 80,3 por ciento. Conclusiones: La resección anterior del recto ultrabaja laparoscópica con anastomosis coloanal es una técnica segura con excelentes resultados en cuanto a recidiva local y supervivencia global(AU)

ABSTRACT Introduction: Laparoscopic ultralow anterior rectal resection with coloanal anastomosis prevents the performance of a definitive colostomy. Objective: To determine the indications, describe the surgical technique and show the long-term outcome of performing this procedure in the treatment of cancer of the lower rectum. Method: A descriptive and prospective observational study of 53 patients with low rectal cancer was carried out in the period between October 2007 and November 2018, at the National Center for Minimum Access Surgery. All resections were carried out by a group dedicated to colorectal surgery. In all cases, the total mesorectal excision was performed. Results: 53 patients (30 males and 23 females), with an average age of 57 years (range 23-81) and 42 (79.2 percent) after neoadjuvant therapy were operated using this technique. The average surgical time was 195 min (range 90-360) and the estimated blood loss was 72 mL. The incidence of major morbidity was 16.9 percent (9/53) and the average hospital stay was 6.3 days. The mean follow-up period was 40 months (range 1-132), with a local relapse of 9.4 percent (5/53) and a 5-year overall survival of 80.3 percent. Conclusions: Laparoscopic ultralow anterior resection of the rectum with coloanal anastomosis is a safe technique with excellent outcomes in terms of local relapse and overall survival(AU)

TAMIS: ¿Un nuevo estándar para el tratamiento de los pólipos de recto? Revisión de la bibliografía y reporte de nuestra experiencia / TAMIS: A new standard for the treatment of rectal polyps? Literature review and report our experience

La morbilidad y alteración de la calidad de vida asociadas a la resección anterior del recto y amputación abdominoperineal determinaron un gran interés en el desarrollo del abordaje transanal. En los últimos años se ha visto un marcado desarrollo tecnológico en los dispositivos disponible para este abordaje. La cirugía por vía transanal ofrece ventajas en cuanto a sus resultados y complicaciones cuando se la compara a la cirugía por vía abdominal. La cirugía transanal mini-invasiva surge como una alternativa de abordaje videoendoscópico del recto. La resección local por cirugía endoscópica para los pólipos grandes de recto se ha convertido en un nuevo estándar de tratamiento en la mayoría de los centros, obteniendo piezas no fragmentadas con una alta tasa de márgenes negativos. En el presente estudio realizamos una revisión sobre la aplicación de TAMIS (TransAnal Minimally Invasive Surgery) al tratamiento de los pólipos de recto. (AU)

A great interest has developed in implementing trans anal minimally invasive surgery for the treatment of rectal adenomas and early rectal tumors. It present advantages when compare to radical surgery and peace meal endoscopic resections. TAMIS delivers non-fragmented specimens with clear resection margin in the majority of the cases. Such good technical results are mirrored with a low recurrence rate when evaluating rectal adenomas. This is a review of the application of TAMIS for the treatment of rectal adenomas. (AU)

Recurrence pattern of rectal cancer after surgical treatment. Analysis of 122 patients in a tertiary care center / Padrão de recorrência de câncer retal em seguida ao tratamento cirúrgico. Análise de 122 pacientes em um centro terciário

ABSTRACT Survival in rectal cancer has been related mainly to clinical and pathological staging. Recurrence is by far the most challenging issue when surgical treatment of rectal cancer is concerned. This study aims to establish a recurrence pattern for rectal adenocarcinoma submitted to surgical treatment between March 2003 and July 2016. After exclusion criteria were applied, one hundred twenty two patients were analyzed. Global recurrence was found in 22% of them, while 13.1% have had local recurrence. Disease-free survival was 23.9 months, in average, and medium follow-up was 34.13 months, varying from 6 to 115 months. Recurrence, in literature, is usually between 3 and 35% in 5 years, and shows a 5-years survival rate of only 5%. Around 50% of cases, recurrence is local, confined to pelvis. This data followed literature in most aspects evaluated, although finding a high rate of local recurrence remains a challenge in the seek for better surgical outcomes.

RESUMO A sobrevida de pacientes com câncer retal tem sido relacionada, sobretudo, aos estadiamentos clínico e patológico. De longe a recorrência é o problema mais desafiador, no que concerne ao tratamento cirúrgico do câncer retal. Esse estudo pretende estabelecer um padrão de recorrência para pacientes com adenocarcinoma retal submetidos a tratamento cirúrgico entre março de 2003 e julho de 2016. Após a aplicação dos critérios de exclusão, foram analisados 122 pacientes. Recorrência global foi constatada em 22% dos pacientes, enquanto que 13,1% tiveram recorrência localizada. A média para sobrevida livre de doença foi de 23,9 meses, e o acompanhamento médio foi de 34,13 meses, com variação entre 6-115 meses. Na literatura, em geral a recorrência se situa entre 3-35% após 5 anos, com um percentual de sobrevida após 5 anos de apenas 5%. Em cerca de 50% dos casos a recorrência é localizada, ficando confinada à pelve. Os presentes dados acompanharam os achados da literatura na maioria dos aspectos avaliados, embora o achado de elevado percentual de recorrência localizada permaneça ainda um aspecto desafiador na busca de desfechos cirúrgicos mais satisfatórios.

Prevalência de câncer colorretal associado ao papilomavírus humano: uma revisão sistemática com metanálise / Colorectal cancer prevalence linked to human papillomavirus: a systematic review with meta-analysis

RESUMO: Introdução: O câncer colorretal é um dos tipos de tumor mais prevalentes na população mundial. A mortalidade causada por esses tumores malignos continua elevada e mantém-se praticamente no mesmo nível nas últimas décadas. Entre os fatores de risco já estabelecidos para o desenvolvimento do câncer estão as infecções por patógenos ou vírus. Entre os vírus, o papilomavírus humano (HPV) é o mais prevalente, tendo mais de 180 cepas, das quais 40 estão diretamente relacionadas com infecções anogenitais. Objetivo: Avaliar de forma sistemática, com metanálise, os principais estudos que associam o HPV ao câncer colorretal. Métodos: Como estratégia de busca foi adotada a lógica baseada em descritores específicos (idioma inglês), vinculados aos operadores booleanos (AND/OR). As buscas foram aplicadas nas bases de dados PubMed, ScienceDirect e Scientific Electronic Library Online (SciELO), no período de abril e maio de 2015. Resultados: Foram avaliadas 1.549 amostras, sendo 956 (61,7%) do sexo masculino. Foram diagnosticados 630/1.358 casos de câncer colorretal por HPV (51,9%). Destes, 408/767 (51,9%) eram do sexo masculino e 404/598 (67,5%) foram associados aos HPVs 16 e 18, com prevalência tumoral na região do colo (253/411; 61,3%). Do total de 598 amostras para estimativa das prevalências de HPV-16 e HPV-18, a quantidade de casos com valores muito semelhantes foi de 204 (31,7%) e 200 (35,8%), respectivamente. Foram verificados valores relativamente expressivos na região do colo, 253 (61,3%), e na região retal, 158 (38,7%). Conclusão: Após a realização do presente estudo, a associação entre HPV e câncer colorretal ficou evidente, não havendo distinção entre gêneros, com valores muito semelhantes entre o HPV-16 e o HPV-18.

ABSTRACT: Introduction: Colorectal cancer is one of the most prevalent types of tumors worldwide. Deaths caused by these malignant tumors remain high and have stayed practically at the same level for the last few decades. Among the established risk factors for the development of cancer are infections due to pathogens or viruses. Among the viruses, the human papillomavirus (HPV) is the most prevalent, with over 180 strains, 40 of which are directly related to anogenital infections. Objective: Systematically assess the main studies which link HPV to colorectal cancer with meta-analysis. Methods: The search strategy adopted was the logic based on specific descriptors (English language), in combination with the Boolean operators (AND/OR). The search was conducted in the following databases: PubMed, ScienceDirect, and Scientific Electronic Library Online (SciELO), between April and May 2015. Results: 1,549 samples were assessed, with 956 (61.7%) being males. Six hundred thirty out of 1,358 cases of colorectal cancer due to HPV were diagnosed (51.9%). From these, 408 of 767 (51.9%) were male and 404 of 598 (67.5%) were linked to HPV 16 and 18, with tumor prevalence in the area of the cervix (253 of 411; 61.3%). From the total of 598 samples for the prevalence estimate of HPV 16 and 18, the number of cases with similar numbers was 204 (31.7%) and 200 (35.8%), respectively. Relatively significant numbers were found in the area of the cervix, 253 (61.3%), and the area of the rectum, 158 (38.7%). Conclusion: After conducting the present study, the link between HPV and colorectal cancer was made evident, without a distinction between the sexes, with similar values between HPV 16 and HPV 18.

Incidence and mortality from colon and rectal cancer in Midwestern Brazil / Incidência e mortalidade por câncer de cólon e reto no Centro-Oeste do Brasil

ABSTRACT: Objective: To describe the incidence and mortality rates from colon and rectal cancer in Midwestern Brazil. Methods: Data for the incidence rates were obtained from the Population-Based Cancer Registry (PBCR) according to the available period. Mortality data were obtained from the Mortality Information System (SIM) for the period between 1996 and 2008. Incidence and mortality rates were calculated by gender and age groups. Mortality trends were analyzed by the Joinpoint software. The age-period-cohort effects were calculated by the R software. Results: The incidence rates for colon cancer vary from 4.49 to 23.19/100,000, while mortality rates vary from 2.85 to 14.54/100,000. For rectal cancer, the incidence rates range from 1.25 to 11.18/100,000 and mortality rates range between 0.30 and 7.90/100,000. Colon cancer mortality trends showed an increase among males in Cuiabá, Campo Grande, and Goiania. For those aged under 50 years, the increased rate was 13.2% in Campo Grande. For those aged over 50 years, there was a significant increase in the mortality in all capitals. In Goiânia, rectal cancer mortality in males increased 7.3%. For females below 50 years of age in the city of Brasilia, there was an increase of 8.7%, while females over 50 years of age in Cuiaba showed an increase of 10%. Conclusion: There is limited data available on the incidence of colon and rectal cancer for the Midwest region of Brazil. Colon cancer mortality has generally increased for both genders, but similar data were not verified for rectal cancer. The findings presented herein demonstrate the necessity for organized screening programs for colon and rectal cancer in Midwestern Brazil.

RESUMO: Objetivo: Descrever o perfil do câncer de cólon e reto no Centro-Oeste do Brasil. Métodos: Os dados de incidência foram obtidos dos Registros de Câncer de Base Populacional (RCBP) de acordo com o período disponível. Dados sobre os óbitos foram obtidos do Sistema de Informação em Mortalidade (SIM). As taxas de incidência e mortalidade foram calculadas por gênero e grupos etários. As tendências de mortalidade foram analisadas pelo software Joinpoint. Os efeitos de idade-período-coorte foram calculados no software R. Resultados: As taxas de incidência do câncer de cólon variaram de 4,49 a 23,19/100.000, e a mortalidade, de 2,85 a 14,54/100.000. A incidência do câncer de reto variou de 1,25 a 11,18/100.000; a mortalidade, de 0,30 a 7,90/100.000. As tendências de mortalidade por câncer de cólon mostraram um aumento entre homens em Cuiabá, Campo Grande e Goiânia. Para aqueles abaixo dos 50 anos, o aumento foi de 13,2% em Campo Grande. Para aqueles acima dos 50 anos, houve um aumento significante em todas as capitais. Em Goiânia, a mortalidade por câncer de reto em homens aumentou 7,3%. Para mulheres abaixo dos 50 anos em Brasília, o aumento foi de 8,7%, enquanto que para mulheres acima dos 50 anos em Cuiabá foi de 10%. Conclusão: Os dados de incidência do câncer de cólon e reto no Centro-Oeste do Brasil são limitados. A mortalidade por câncer de cólon tem aumentado para ambos os sexos, mas o mesmo não foi verificado para câncer de reto. Os resultados demonstram a necessidade de programas organizados de rastreamento para esta neoplasia no Centro-Oeste.

Tracheobronchopathia osteochondroplastica: A rare cause of difficult intubation.

Tracheobronchopathia osteochondroplastica is a rare benign airway disorder which is characterised by submucosal nodules projecting into the tracheo-bronchial lumen usually involving the cartilaginous portions of the tracheo-bronchial tree or larynx. The condition is usually asymptomatic but can rarely present with difficulty during endotracheal intubation or rarely with obstructive airway complications. Bronchoscopic appearance is usually sufficient to make the diagnosis, and tissue biopsies are seldom required. No specific treatment is required in asymptomatic patients. However, interventional bronchoscopy procedures or surgery may be helpful in symptomatic cases.

Prevalencia de adenomas y adenocarcinomas de recto-sigma en pacientes menores de 50 años que consultan por proctorragia / [Prevalence of rectosigmoid adenomas and adenocarcinomas in patients younger than 50 years old referred for proctorrhagia].

BACKGROUND: Rectal bleeding is a sign of colorectal cancer (CRC). Its early diagnosis decreases mortality and improves survival. In young population with no risk factors for the disease, CRC is infrequent. Moreover, benign anorectal disorders are most frequent causes of bleeding and generally, when anal pathology is identified, it is assumed as the origin of the sign. For all these reasons, rectal bleeding sometimes is sub-assessed in young patients. OBJECTIVE: Estimate the prevalence of adenomas and adenocarcinomas in sigmoid and rectum in patients younger than 50 years old referred for proctorrhagia. METHODS: The study design was descriptive, retrospective and cross-sectional. Procedures were performed under sedation and Olympus CF 160 y CF 180 scopes were used. Proctorrhagia was considered as rectal bleeding registered as indication of the procedure. Histology was established according to Vienna classification. Informed consent was signed before the procedures. Colonoscopy reports were reviewed. The study took place in an outpatient clinic in Buenos Aires city, between October 2010 and October 2011. High risk patients for CRC were excluded RESULTS: We included 1,203 from 1,257 reviewed VCC, 49

were female and the median age was 38 years old (range: 18-49 years old). The prevalence of adenomas and adenocarcinomas in sigmoid and rectum was 67

CI): 5.4-8.3] and 1.6

CI 1-2.5), respectively. CONCLUSIONS: Adenocarcinomas and adenomas are infrequent in a young population without risk factors for CRC. However, even when benign anal disorders are the most frequent cause for rectal bleeding, miss evaluation of this sign could have a serious impact in almost 10 of 100 individuals.

Clinical and epidemiological evaluation of patients with colorectal cancer from Rio Grande do Sul

Colorectal cancer has a high incidence in Brazil, with the South and Southeast regions presenting the largest number of cases. OBJECTIVE: Identify the epidemiological characteristics and the regimens used as first-line treatment of patients with colorectal cancer treated at a cancer center in Santa Cruz do Sul (RS, Brazil) from 2006 to 2011. METHODS: The records of 130 patients were retrospectively evaluated. Clinical and epidemiological characteristics, such as age, gender, ethnic group, stage of disease, primary site of disease and first-line treatment, were evaluated. The association of significance was evaluated using the chi-square and Fischer exact tests. The confidence interval used was 95% (p<0.05). RESULTS: The mean age of patients with colorectal cancer in this study was 60.8 years, with higher incidence of the disease in men. At diagnosis, 40% of the patients had advanced disease stage IV. The regimen of 5-fluorouracil/folic acid (68.5%) was used as first-line treatment. CONCLUSION: This study showed high prevalence of colorectal cancer in patients of advanced age with the diagnosis made in the later stage of the disease. This fact demonstrates the importance of prevention campaigns that encourage periodic examinations in patients over 50 years of age. (AU)

No Brasil, o câncer colorretal apresenta uma elevada incidência, sendo as Regiões Sul e Sudeste as com maior número de casos. OBJETIVO: Identificar as características epidemiológicas e os esquemas terapêuticos utilizados como primo-tratamento dos pacientes portadores de câncer colorretal atendidos em um centro especializado em oncologia em Santa Cruz do Sul (RS) no período de 2006 a 2011. MÉTODO: Foram avaliados retrospectivamente 130 prontuários de pacientes portadores de câncer colorretal. Características clínicas e epidemiológicas como idade, sexo, cor da pele, estádio da doença, sítio primário da doença e primo-tratamento foram avaliadas. A associação de significância foi avaliada pelos testes do qui-quadrado e exato de Fischer. O intervalo de confiança utilizado foi de 95% (p<0,05). RESULTADOS: A idade média dos pacientes encontrada neste estudo foi de 60,8 anos com incidência maior da doença entre os homens. No momento do diagnóstico, 40% dos pacientes estavam com a doença no estádio IV. Como primo-tratamento o esquema terapêutico mais utilizado foi o 5-fluoracil/ácido folínico (68,5%). CONCLUSÃO: Este estudo ratificou a alta prevalência do câncer colorretal em pacientes com idade mais avançada, com o diagnóstico realizado na fase mais avançada da doença. Esse fato evidencia a importância da realização de campanhas de prevenção que estimulem a realização de exames periódicos nos pacientes com idade acima de 50 anos. (AU)

Anastomotic leakage following low anterior resection of rectal cancer considering the role of protective stoma

Probable risk factors of clinical anastomotic leakage and the role of defunctioning stoma in patients undergoing low anterior resection [LAR] for rectal cancer, is still controversial. The goal of our study was to find out possible risk factors of anastomotic leakage and to locate the influence of protective stoma in the rate of anastomotic leakage. In this retrospective study, 44 patients underwent LAR with total mesorectal excision [TME] during the period from 2001 to 2006 were analyzed. From these 44 patients 24 were treated with protective stoma while 20 were not. Overall anastomotic leakage rate was similar among patients with and without protective stoma [odds ratio=0.51, P=0.2357]. Male gender, Low anastomosis, Coronery Artery Disease, preoperative radiotherapy, and smoking were great risk factors for developing anastomotic leakage. We did not find any differences between handsewn and stapled anastomosis [odds ratio = 0.6]. protective stoma will be helpful depending on surgeon experiences and is not recommended for all the patients routinely. Beside this, male gender, low anastomosis, coronary artery disease, preoperative radiotherapy, and smoking are the major risk factors of anastomotic leakage

Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India.

Time trends in cancers of the esophagus, stomach, colon, rectum and liver cancers among the male population in five Indian urban population based cancer registries (Mumbai, Bangalore, Chennai, Delhi, and Bhopal) were examined over the period of the last two decades. The model applied fits data to the logarithm of Y=ABx. This Linear Regression method showed decreasing trends in age-adjusted incidence rates for cancers of the stomach and esophagus, especially in Bjopal, and increasing trends for colon and rectum and liver, throughout the entire period of observation in most of the registries. The five cancers together constitute more than 80% of the total gastro intestinal cancers and are serious diseases in both sexes. To understand the etiology of these cancers in depth, analytic epidemiological studies should be planned in the near future on a priority basis.

Tendencia del cáncer colorectal en una zona del norte de España / Tendency of the Colorectal Cancer in a zone of northern Spain

Introducción: Las tasas de cáncer colorectal están aumentando en varios países. Para investigar este hecho hemos analizado las tasas de incidencia en una zona del Norte de España entre 1992 y 2005. Métodos: hemos calculado las tasas de incidencia del cáncer de colon y recto, así como la tendencia por el método de Joinpoint. Resultados: Se observa un porcentaje anual de cambio (APC) de 7.34 en mujeres y 10.10 en hombres, ambos estadísticamente significativos. En cambio no se encuentra variación en el cáncer de recto. Conclusiones: también en España se están encontrando notables incrementos de cáncer de colon, aunqueno de recto. Es preciso seguir monitorizando esta tendencia y evaluar los factores de riesgo para esta enfermedad.

Background: The colorectal cancer incidence rates have been rapidly increasing. In order to investigate trends in colorectal cancer incidence rates we analyzed incidence data between 1992 and 2005 in the North of Spain. Methods: Using Joinpoint models, we evaluated the effects of time period on colon and rectal cancer incidence. Results: The analysis found a significant annual percentage of change (APC) (7.34) on female colon cancer incidence, and a significant APC (10.10) in male incidence. For incidence rectal cancer significant cohort effect was found comparing males and females. Conclusions: Owr study shows a significant continuous increase incidence of colon cancer in Spain. We suggest to follow monitoring of cancer incidence and assessing risk factors.

Endorectal ultrasonography in rectal cancer: a preliminary Barbadian experience / La ultrasonografía endorectal en el cáncer del recto: una experiencia preliminar barbadense

Preoperative staging of rectal cancer assists in surgical decision making regarding the suitability of curative local excision as well as in the selective use of preoperative adjuvant radiation and chemoradiation, both of which have been shown to reduce the incidence of loco-regional cancer recurrence substantially. Most colorectal units employ endorectal ultrasound (ERUS) in the assessment to define tumour depth (T) and nodal (N) status. The preliminary Barbadian experience of 40 such cases showing an accuracy for T stage of 85% and for N stage of 50% in keeping with international reports is presented The interpretation and limitations of this technology are presented

La estadificación preoperatoria del cáncer rectal ayuda en la toma de decisiones en relación con la conveniencia de la excisión local curativa, así como en el uso selectivo de la radiación adyuvante preoperatoria y la quimoradiación, las cuales han probado su eficacia en cuanto a reducir sustancialmente la incidencia de la recurrencia del cáncer loco-regional. La mayor parte de las unidades colorectales emplean el ultrasonido endorectal (UER) en la evaluación para definir la profundidad del tumor (T) y el estatus nodal (N). Se presenta la experiencia preliminar barbadense en 40 de estos casos, que muestran una precisión del 85% para el estado T y del 50% para el estado N en correspondencia con los reportes internacionales. Se presentan la interpretación y las limitaciones de esta tecnología.